Induction of S phase arrest and apoptosis by ethyl acetate extract from Tetrastigma hemsleyanum in human hepatoma HepG2 cells
- 330 Downloads
Tetrastigma hemsleyanum, a rare and endangered medicinal plant, has attracted much attention due to antitumor and immunomodulatory activities. In this study, the effect and mechanism of ethyl acetate extract from T. hemsleyanum (EET) on cell cycle and apoptosis in human hepatoma HepG2 cells were investigated. Twenty-five to 200 μg/mL of EET were found to have the antiproliferation effect toward HepG2 cells determined by MTT assay. The morphology of EET-treated HepG2 cells showed evidence of apoptosis that included blebbing and chromatin condensation, nucleic fragmentation, and so on. The DNA laddering assay confirmed that DNA fragmentation had occurred during late apoptosis. The cell-cycle analysis indicated that EET was able to induce S phase arrest and typical subdiploid peak in a dose- and time-dependent manner. The apoptosis rate of 200 μg/mL treatment for 24 h was 42.24 ± 4.90 %. The protein expression of Bax and P53 was increased after treatment, while that of Bcl2 was significantly decreased in a dose-dependent manner, which suggested that a high Bax/Bcl2 ratio and an upregulated P53 might contribute to the pro-apoptotic activity of EET via the mitochondria-dependent pathway. The protein expression of cyclin-dependent kinase 1 (CDK1) was decreased in EET-treated HepG2 cells, suggesting that EET evoked S phase arrest possibly through the downregulation of cyclin A-CDK1 complex. In conclusion, the cytotoxicity on HepG2 cells induced by EET is a result of both cell-cycle arrest and apoptosis. Thus, it may have therapeutic potential for the treatment of liver cancer.
KeywordsTetrastigma hemsleyanum HepG2 cells Apoptosis Cells cycle arrest
This work was supported by the traditional Chinese medical science technology research projects of Zhejiang Province (Grant No. 2013ZA119), the public welfare technology research projects of Zhejiang Province (Grant No. 2013C32103), and the agricultural research projects of Ningbo City (Grant No. 2014C10031).
- 9.He FG. Research progress in anticancer effect of Tetrastigma hemsleyanum Diels et Gilg and its mechanism. J Oncol. 2010;16:75–7 (in Chinese).Google Scholar
- 10.Yuming Y, Yili W, Yeling T, Guanhai D. Comparative study on anti-tumor effects of different processed Tetrastigma hemsleyanum Diels et Gilg on Lewis lung cancer and H22 liver cancer in mice. Chin Arch Tradit Chin Med. 2013;31:2674–6 (in Chinese).Google Scholar
- 11.Feng Z-Q, Ni K-F, He Y, Ding Z-S. Experimental study on effect of Tetrastigma hemsleyanum Diels et Gilg flavone on inducing apoptosis of SGC-7901 cell line in vitro. Chin J Clin Pharmacol Ther. 2006;11:669–72. in Chinese.Google Scholar
- 12.Ding G-Q, Zhen J-X, Wei K-M, Pu J-B. Toxicological effects of the extract of Tetrastigma hemsleyanum Diels et. Gllg on hepatocellular carcinoma cell line HepG2 and primary rat hepatocytes in vitro. Zhejiang Prev Med. 2005;17:1–5. in Chinese.Google Scholar
- 18.Liu D, Ju JH, Lin G, Xu XD, Yang JS, Tu GZ. New C- glycosylflavones from Tetrastigma hemsleyanum (Vitaceae). Acta Bot Sin. 2002;44:227–9.Google Scholar